Medication Education · Product Transparency

Medication & Product Facts

Last reviewed: August 21, 2026 · Educational information only

Read this first. NoTimeRx primarily coordinates prescription treatment pathways that may involve customized, patient-specific compounded medications when an independent licensed healthcare provider determines that compounding is clinically appropriate and a licensed pharmacy is able to lawfully prepare and dispense the prescription. Compounding is a longstanding part of pharmacy practice and can be especially useful when a patient needs something that is not readily available in a standard commercially manufactured product, such as a particular strength, dosage form, combination of ingredients, topical base, capsule type, delivery method, or other individualized formulation. Compounded medications are not FDA-approved in the same way that commercially manufactured prescription drugs are. This is an important regulatory distinction, but it should not be interpreted as meaning that compounded medication is automatically inferior, inappropriate, or unsuitable simply because it is compounded. Rather, compounded medications follow a different regulatory pathway. The FDA does not individually approve each patient-specific compounded preparation before it is dispensed. Instead, compounding is generally performed by appropriately licensed pharmacies operating under applicable federal and state pharmacy requirements, with the prescription and clinical decision made by an independent licensed provider. The purpose of compounding is often customization. Depending on the patient, prescription, pharmacy capabilities, and applicable law, a compounded medication may allow a provider to prescribe a strength that is not commercially available, remove or substitute certain inactive ingredients, use a different dosage form, combine compatible ingredients into a single preparation, or select a delivery vehicle that better fits the intended treatment plan. Not every requested formulation can or should be compounded, and the final prescription remains subject to the independent provider's clinical judgment and the dispensing pharmacy's professional and regulatory requirements. NoTimeRx itself is a non-clinical management services organization and technology platform. We help facilitate access, intake, administrative coordination, payment, pharmacy routing, and other support functions. Independent licensed healthcare providers make prescribing and treatment decisions, and licensed pharmacies are responsible for preparing and dispensing compounded prescriptions. It is also important to understand that not every product available through NoTimeRx is a compounded medication. Depending on the product or treatment pathway, an item may be a compounded prescription, an FDA-approved prescription medication, an over-the-counter drug, a dietary supplement, a cosmetic, or another personal-care or wellness product. We aim to identify these categories clearly on product pages and product labeling so patients can understand what type of product they are considering or receiving. This page is intended to explain those distinctions in plain language. It covers what compounded medication means, how customized formulations may differ from commercially manufactured medications, how prescribing and pharmacy responsibilities are divided, and how NoTimeRx identifies the different prescription and non-prescription product categories that may appear across the platform.

✓

CUSTOM

RX OTC SUPP

What controls your care. This page is not a prescription, diagnosis, dosing guide, or substitute for the dispensing label, patient-specific directions, Medication Guide, current FDA-approved prescribing information when applicable, or instructions from your provider and dispensing pharmacy. If anything on this page conflicts with your label or provider instructions, stop and ask the provider or pharmacy before using the product.

1. What You May Receive Through NoTimeRx

NoTimeRx is operated by Biotica Consulting LLC d/b/a NoTimeRx as a non-clinical management services organization and technology platform. Depending on the product, your state, provider judgment, pharmacy availability, and applicable law, an item shown on the website may fall into one of several different categories.

COMPOUNDED RX

Compounded prescription medication

Prepared by a licensed pharmacy for a patient under a valid prescription. The exact finished preparation is not FDA-approved.

FDA-APPROVED RX

FDA-approved prescription medication

A finished prescription drug approved by FDA for one or more labeled uses. A provider may also prescribe it off-label when clinically appropriate.

OTC DRUG

Over-the-counter medication

A nonprescription drug sold with a Drug Facts label that lists active ingredients, uses, warnings, and directions.

DIETARY SUPPLEMENT

Dietary supplement

A product regulated as a dietary supplement, not as an FDA-approved drug. It should carry a Supplement Facts panel.

PERSONAL CARE

Cosmetic or personal-care product

A nonprescription product intended for cleansing, appearance, grooming, or another non-drug purpose unless the label states otherwise.

Do not infer the category from the ingredient name alone. The same or a similar ingredient can appear in different product categories, concentrations, dosage forms, or intended uses. Read the category badge, product page, checkout disclosure, dispensing label, Drug Facts panel, or Supplement Facts panel. If a category is missing or unclear, contact support before ordering.

2. What a Compounded Medication Is

Drug compounding is the practice of combining, mixing, or altering ingredients to create a medication for a patient's needs. In common patient-specific pharmacy compounding, a licensed provider writes a prescription and a licensed pharmacist prepares the medication under the laws and standards that apply to that pharmacy and prescription.

A compounded prescription may be used to create or adjust:

Strength or concentration. A provider may prescribe a strength that is not commercially available in the needed dosage form.
Dosage form. A medication may be prepared as a capsule, liquid, troche, cream, gel, foam, solution, suspension, suppository, or another lawful form.
Inactive ingredients. A pharmacy may omit or substitute certain dyes, flavors, fillers, oils, preservatives, or other excipients when clinically appropriate and technically feasible.
Route or vehicle. The provider and pharmacy may select a vehicle or route that better fits the treatment plan, while accounting for absorption, stability, compatibility, and safety.
Combination formula. Compatible ingredients may sometimes be combined into one patient-specific preparation when the provider and pharmacy determine that it is clinically appropriate and lawful.
Quantity and dispensing format. The quantity, container, applicator, syringe, pump, or measuring device may differ from mass-manufactured products.

Customized does not mean self-designed. You may be able to state preferences or report prior reactions, but the provider decides whether treatment is appropriate and what to prescribe. The pharmacy decides whether the formula can be lawfully and safely compounded, whether the ingredients are compatible, what beyond-use date applies, and how the product must be packaged and stored.

3. "Not FDA-Approved" Requires Nuance

FDA approval is a formal regulatory determination about a specific finished drug product, its manufacturing controls, labeling, evidence, and approved uses. Compounded drugs do not go through that same premarket approval process.

What it means

FDA has not approved the exact compounded finished preparation.
FDA has not verified that preparation's safety, effectiveness, or quality before marketing.
The preparation is not automatically a generic drug or therapeutically equivalent to a brand product.
Its concentration, inactive ingredients, dosage form, packaging, stability, and instructions may differ from an approved product.
Oversight and quality requirements depend in part on whether it is prepared under section 503A or section 503B and on applicable state law.

What it does not automatically mean

It does not prove that every compounded medication is unsafe.
It does not mean compounding has no legitimate medical purpose.
It does not mean the product was made without a prescription, pharmacist, or professional oversight.
It does not make a lawfully dispensed compounded medication the same as an unverified product sold by an unknown internet source.
It does not guarantee safety either. The ingredient, dose, route, sterility, pharmacy practices, patient factors, monitoring, and correct use all matter.

The balanced fact is that compounding can serve an important patient need, while poor compounding practices, contamination, incorrect strength, unstable formulas, labeling problems, or dosing mistakes can cause serious harm. The goal is not to treat "compounded" as automatically good or automatically bad. The goal is to understand why it is being used, who prepared it, what the label says, how to measure it, and what monitoring is required.

4. Compounded, Brand, and Generic Drugs Are Different

BRAND

FDA-approved brand drug

The manufacturer obtained FDA approval for that finished product, labeling, formulation, and approved use or uses.

GENERIC

FDA-approved generic drug

A generic is also FDA-approved and must satisfy the applicable approval requirements, including requirements related to equivalence to its reference drug.

COMPOUNDED

Compounded drug

The exact finished preparation is not FDA-approved. It should not be described as FDA-approved, a generic version, identical, interchangeable, or clinically proven to produce the same result as an approved product.

A compounded preparation may contain an ingredient that is also used in an FDA-approved drug. That fact alone does not make the compounded finished product FDA-approved or equivalent to the approved product. The source, form, strength, concentration, excipients, route, container, and preparation process can all matter.

5. Why a Provider May Consider Compounding

A provider may consider a compounded medication when, for example:

An FDA-approved product does not meet the patient's specific clinical need.
A needed strength or dosage form is not commercially available.
A patient cannot swallow a tablet or needs another route.
A patient has a documented sensitivity or allergy to an inactive ingredient.
A compatible patient-specific combination may simplify a regimen.
An approved drug is not commercially available and compounding is permitted under the applicable shortage rules.

Compounding should not be presented as automatically better, stronger, safer, or more effective. It is one possible clinical and pharmacy pathway. Availability, convenience, price, or a patient's request does not require a provider to prescribe a compounded medication.

6. Section 503A and Section 503B

503A

Traditional patient-specific compounding

Section 503A generally concerns compounding by a licensed pharmacist in a state-licensed pharmacy or federal facility, or by a licensed physician, when the statutory conditions are met. A central condition is a valid patient-specific prescription. State boards of pharmacy generally have primary day-to-day oversight of state-licensed pharmacies that are not registered as outsourcing facilities.

503B

Registered outsourcing facilities

Section 503B created a voluntary category called outsourcing facilities. These facilities register with FDA, are subject to current good manufacturing practice requirements, report certain information, and are inspected by FDA on a risk-based schedule. They may distribute certain compounded drugs for patient-specific use or office stock when legal conditions are satisfied.

Registration is not approval. A pharmacy, compounder, or outsourcing facility should not be called "FDA-approved" or "FDA-licensed." FDA does not grant those designations to compounding facilities. A 503B facility may be FDA-registered and inspected, but its compounded drugs are still not FDA-approved.

7. Who Does What

NoTimeRx, the MSO and platform

NoTimeRx may provide intake technology, account tools, administrative routing, scheduling, payment coordination, support, communications, and pharmacy or laboratory coordination. NoTimeRx does not practice medicine or pharmacy, diagnose, prescribe, compound, or dispense medication.

Independent licensed provider

The provider reviews the clinical information, determines whether telehealth is appropriate, requests any needed visit or testing, decides whether to prescribe, selects the treatment and directions, obtains informed consent when required, and manages clinical follow-up.

Independent licensed pharmacy

The pharmacy performs its own prescription review, confirms it can lawfully dispense the product, compounds or fills the prescription, determines preparation and packaging details, applies the beyond-use date or expiration date, labels the product, and provides pharmacy contact information and any counseling required by law.

Manufacturer or nonprescription vendor

OTC drugs, supplements, cosmetics, and personal-care products may be manufactured or fulfilled by third parties. Their applicable Drug Facts, Supplement Facts, ingredient list, directions, warnings, and return restrictions remain important.

8. Product Category and Transparency Commitments

NoTimeRx will identify the applicable product category on the website before purchase. For a dispensed prescription, the independent pharmacy is responsible for the final physical label, directions, pharmacy identification, storage information, and beyond-use date or expiration date. For a nonprescription product, the manufacturer or vendor is responsible for the applicable Drug Facts, Supplement Facts, cosmetic, ingredient, or other required labeling.

Our product-transparency commitments. We will not describe a compounded drug as FDA-approved, a generic version, identical to an FDA-approved product, or guaranteed to produce the same result. We will distinguish prescription products from OTC drugs, dietary supplements, cosmetics, and personal-care items. We will also make clear that website availability does not guarantee provider approval, pharmacy fulfillment, or suitability for a particular patient.

The website category labels use the following meanings:

COMPOUNDED PRESCRIPTION means provider approval and a valid prescription are required, and the exact finished preparation is not FDA-approved.
FDA-APPROVED PRESCRIPTION means the finished drug is FDA-approved, although the provider may prescribe it for an off-label use.
OVER-THE-COUNTER DRUG means no prescription is required and the Drug Facts label controls safe use.
DIETARY SUPPLEMENT means the item is not an FDA-approved drug and should have a Supplement Facts panel.
COSMETIC OR PERSONAL CARE means the item is sold for a non-drug purpose unless its label clearly states otherwise.

A product may be unavailable in your state, unavailable from the selected pharmacy, changed to another lawful formulation, or declined by the provider. A website listing is not a guarantee of prescription approval, pharmacy fulfillment, insurance coverage, or a particular result.

9. How to Read the Label You Receive

For a prescription medication

Confirm your name and the dispensing pharmacy.
Confirm the active ingredient or ingredients, strength, concentration, and dosage form.
Read the route and directions exactly. "Apply," "swallow," "place under the tongue," and "inject" are not interchangeable.
Check storage instructions, including refrigeration, protection from light, shaking, or room-temperature limits.
Check the beyond-use date or expiration date. Do not use the product after that date unless the pharmacy specifically authorizes it.
Confirm the measuring device and units. Milligrams, milliliters, pumps, drops, and syringe units are not interchangeable.
Contact the pharmacy before use if the label, appearance, seal, temperature, concentration, or instructions seem wrong.

For an OTC drug

Read the Drug Facts panel. It identifies the active ingredient, purpose, uses, warnings, directions, inactive ingredients, and other information. Do not assume that an OTC drug is risk-free or appropriate with every prescription medication.

For a dietary supplement

Read the Supplement Facts panel, serving size, ingredient list, allergen information, warnings, and manufacturer information. FDA does not approve dietary supplements for safety and effectiveness before marketing. Supplements can still cause side effects, contain allergens, and interact with prescription or OTC medications.

10. What Happens Before a Prescription Is Fulfilled

Intake and identity

You provide accurate identity, location, health history, medications, supplements, allergies, pregnancy information, and the reason for seeking care.

Independent clinical review

The provider may approve, deny, defer, request more information, order testing, require a phone or video visit, or refer you to in-person care.

Prescription and pharmacy review

If treatment is appropriate, the provider sends a prescription. The pharmacy performs its own legal, clinical, formulation, and dispensing review.

Preparation, labeling, and delivery

The pharmacy or vendor prepares or fills the order, applies the final label and instructions, packages it, and coordinates shipment or pickup.

11. General Safety Facts for Customized Medications

A different appearance can be normal, but it must be explained. Color, texture, taste, odor, viscosity, capsule color, pump size, or bottle shape may differ between pharmacies or refills. Ask before use if the difference is unexpected.
Concentration matters. Two bottles with the same ingredient name may contain different concentrations. Never reuse old dosing instructions without checking the new label.
Beyond-use dates are important. A compounded product's beyond-use date may be shorter than the expiration date commonly seen on mass-manufactured products.
Sterile and nonsterile products are not the same. Injectable, ophthalmic, and certain other sterile preparations require additional controls. Never inject a product unless it was specifically prescribed, prepared, and labeled for injection.
Storage can affect quality. Heat, freezing, light, moisture, or delayed refrigeration can damage some products. Contact the pharmacy if shipping conditions were outside the label requirements.
Do not share medication. A patient-specific prescription is for the named patient only, even when another person has similar symptoms.
Do not transfer topical medication. Wash hands when directed, allow the product to dry, and avoid unintended skin contact with children, pregnant people, partners, or pets when the ingredient can be absorbed or cause harm.
Do not change the dose yourself. More product is not automatically more effective and can increase adverse effects.

12. Selected Medication and Ingredient Facts

This section is selective, not complete. It highlights a few reasons a provider may ask detailed questions or require testing. The absence of a warning from this page does not mean a product has no contraindications, interactions, or monitoring requirements.

Methylene blue

Methylene blue has important interaction and blood-cell risks. FDA-approved injectable labeling warns about serious or fatal serotonin syndrome when methylene blue is combined with serotonergic drugs and certain opioids, and it contraindicates use in people with G6PD deficiency because of hemolytic anemia risk. A compounded oral or other preparation is not the FDA-approved injectable product and may involve a different route, use, evidence base, and risk assessment.

Disclose antidepressants, MAO inhibitors, tramadol, dextromethorphan, linezolid, opioids, stimulants, migraine medicines, and serotonergic supplements.
Do not stop a psychiatric or pain medication merely to qualify for methylene blue without the prescribing clinicians coordinating a safe plan.
Seek urgent care for agitation, confusion, high fever, severe sweating, muscle rigidity, tremor, seizures, rapid heart rate, dark urine, yellowing of the skin or eyes, severe weakness, or shortness of breath.
Blue or green urine or stool can occur, but a color change does not prove that the product is safe or that a concerning symptom can be ignored.

Isotretinoin and iPLEDGE

Isotretinoin can cause severe embryo-fetal harm and FDA-approved isotretinoin products are subject to the FDA-required iPLEDGE REMS. Any isotretinoin service offered through NoTimeRx must use a lawful dispensing pathway and follow the current iPLEDGE requirements that apply to the patient, prescriber, and pharmacy. Program requirements can change, so current iPLEDGE instructions and pharmacy rules control.

NoTimeRx does not treat a lower-dose or "microdose" protocol as exempt from iPLEDGE requirements.
Never use isotretinoin during pregnancy and never share it.
Complete required pregnancy testing, attestations, counseling, and dispensing windows exactly as instructed.
Discuss dry skin, eye symptoms, severe headache or vision changes, mood changes, abdominal symptoms, and any laboratory monitoring with the provider.

Finasteride and dutasteride

Finasteride and dutasteride reduce conversion of testosterone to dihydrotestosterone. Oral finasteride products are FDA-approved for specific indications. Dutasteride is FDA-approved for benign prostatic hyperplasia, while use for hair loss is off-label. There is currently no FDA-approved topical finasteride product in the United States.

Compounded topical finasteride can be systemically absorbed. "Topical" does not mean zero systemic risk.
Potential adverse effects can include sexual, mood, fertility, breast, and local skin effects. Report meaningful or persistent symptoms.
Topical transfer to another person is possible. Use handling precautions and avoid exposure during pregnancy.
Finasteride and dutasteride can affect prostate-specific antigen interpretation. Tell the clinician ordering or interpreting a PSA test.
Pregnant people should not handle crushed or broken finasteride tablets or leaking dutasteride capsules, and should avoid contact with topical preparations.

Oral minoxidil

Oral minoxidil is FDA-approved as a potent antihypertensive drug, not as a hair-loss medication. Low-dose use for hair loss is off-label. Even at lower doses, a provider may need to consider blood pressure, heart history, fluid retention, kidney status, other blood-pressure medicines, and pregnancy.

Possible effects include lightheadedness, rapid heart rate, ankle swelling, fluid retention, headache, and unwanted facial or body hair.
Seek urgent care for chest pain, fainting, severe shortness of breath, rapidly worsening swelling, or another severe cardiovascular symptom.
Do not increase the dose based only on shedding or perceived slow progress.

Low-dose naltrexone

Naltrexone is FDA-approved at standard doses for certain substance-use disorders. Lower-dose use for other conditions is off-label. Naltrexone blocks opioid receptors and can interfere with opioid pain treatment or precipitate withdrawal in a person who is physiologically dependent on opioids.

Disclose prescription opioids, illicit opioids, tramadol, opioid-containing cough products, recent opioid use, and planned surgery.
Do not start, stop, or time naltrexone around opioids without a clinician's plan.
Tell emergency and surgical clinicians that you use naltrexone because it may change pain-management planning.

Doxepin for sleep

FDA-approved low-dose doxepin exists for sleep-maintenance insomnia. A compounded troche, liquid, or different strength is not the FDA-approved finished product. Doxepin can cause sedation and has important contraindications and interactions.

Untreated narrow-angle glaucoma, severe urinary retention, and current or recent MAOI use require special attention and may be contraindications.
Alcohol, opioids, benzodiazepines, sedating antihistamines, and other central nervous system depressants can increase impairment.
Allow enough time for sleep and do not drive or operate machinery until you know how the medication affects you.

Flibanserin (Addyi)

FDA-approved Addyi is indicated for acquired, generalized hypoactive sexual desire disorder in women younger than 65 when the condition causes marked distress and is not explained by another medical or psychiatric condition, relationship problem, or medication effect. It is not an aphrodisiac and is not indicated to enhance sexual performance.

Alcohol timing matters because the combination can increase hypotension and fainting risk. Follow the current approved label and provider instructions.
Moderate or strong CYP3A4 inhibitors and hepatic impairment are contraindications for the approved product.
Dizziness, sleepiness, nausea, fatigue, insomnia, and dry mouth can occur.

Sildenafil and tadalafil

PDE5 inhibitors can cause a dangerous drop in blood pressure when combined with nitrates or nitrites. This includes nitroglycerin, isosorbide products, and recreational "poppers."

Never combine a PDE5 inhibitor with nitrates unless emergency clinicians who know exactly when the PDE5 inhibitor was taken direct otherwise.
Tell the provider about heart disease, low blood pressure, recent cardiovascular events, alpha blockers, kidney or liver disease, vision history, and prior priapism.
Seek emergency care for an erection lasting longer than four hours, chest pain, sudden vision loss, or sudden hearing loss.

hCG, clomiphene, letrozole, spironolactone, and other hormone-related medications have different FDA-approved indications, off-label uses, monitoring needs, and pregnancy risks. Enclomiphene is not an FDA-approved standalone drug in the United States. A provider may require laboratory testing, semen analysis, pregnancy testing, blood-pressure review, imaging, or referral to an in-person fertility specialist.

Telehealth cannot replace procedures such as ultrasound follicle monitoring, HSG, egg retrieval, embryo transfer, IUI, IVF, or surgical sperm retrieval.
Fertility treatment can increase the chance of multiple gestation or ovarian complications depending on the medication and protocol.
Spironolactone can raise potassium and may require kidney function and potassium monitoring.
Do not use another person's hormone medication or alter injection doses without the prescribing clinician.

GLP-1 receptor agonists and compounded injectables

FDA-approved GLP-1 drugs and compounded GLP-1 preparations are not the same products. The exact legal availability of compounding can change with drug-shortage status, the ingredient source, the pharmacy type, the patient's medical need, and current federal and state rules.

Do not accept a claim that a compounded product is a generic or identical version of an FDA-approved GLP-1 drug.
Concentrations can differ between compounded vials. Confirm the dose in milligrams and the exact volume or syringe units for the bottle you received.
Never convert milligrams, milliliters, and syringe units from memory or an internet chart.
Contact the pharmacy if an injectable product arrives warm when the label requires refrigeration, has a broken seal, lacks clear directions, or lists a pharmacy you cannot verify.
Severe or persistent vomiting, dehydration, severe abdominal pain, signs of gallbladder disease, or symptoms of low blood sugar require prompt medical attention.

Metronidazole and boric acid vaginal products

Vaginal metronidazole is a drug. Boric acid vaginal suppositories are not interchangeable with oral products and must never be swallowed. Recurrent vaginal symptoms can have multiple causes and may require testing rather than repeated self-treatment.

Boric acid is for vaginal use only when specifically labeled and recommended. Oral ingestion can be toxic.
Keep suppositories away from children, pets, and anyone who may mistake them for oral capsules.
Do not use boric acid in pregnancy unless a qualified clinician specifically directs it.
Fever, pelvic pain, pregnancy, bleeding, sores, or symptoms that do not improve require medical evaluation.

Metformin

Metformin is FDA-approved for type 2 diabetes. Use for PCOS or other goals may be off-label. Kidney function, dehydration, alcohol use, liver disease, acute illness, and certain procedures can affect safe use.

Gastrointestinal effects are common, particularly during initiation or dose changes.
Long-term use can contribute to vitamin B12 deficiency in some patients.
Tell the provider about kidney disease and upcoming imaging or surgery. Do not independently stop or restart metformin around a procedure.

Topical retinoids

Tretinoin and tazarotene are prescription retinoids. They can cause dryness, irritation, peeling, and sun sensitivity. Tazarotene has specific pregnancy restrictions. Product strength, vehicle, and frequency matter.

Use sun protection and follow the application schedule given by the provider.
Do not combine multiple irritating acids, scrubs, retinoids, or benzoyl peroxide schedules without guidance.
Report severe irritation, swelling, blistering, or pregnancy immediately.

Dietary supplements

Dietary supplements are regulated differently from drugs. FDA does not approve them for safety and effectiveness before marketing. Manufacturers and distributors are responsible for ensuring that products are not adulterated or misbranded and that claims are lawful.

A supplement can still have pharmacologic effects, side effects, contamination risk, allergens, or drug interactions.
"Natural" does not mean safe for every person, dose, pregnancy, surgery, or prescription regimen.
A structure or function claim is not the same as proof that a supplement treats, cures, or prevents a disease.
Disclose all supplements to the provider, including herbs, vitamins, sleep aids, pre-workouts, and sexual-health products.

Peptides and emerging ingredients

Many peptides and emerging ingredients promoted online are not FDA-approved finished drugs, and some have limited human safety data or face specific federal compounding restrictions. A product being discussed online, nominated for a compounding list, or sold as "research use only" does not make it lawful or appropriate for human treatment.

A research-use-only material should not be presented as a consumer medication or dietary supplement for human use.
Availability must be evaluated substance by substance, route by route, pharmacy by pharmacy, and under current law.
A product page or educational reference does not guarantee that a provider will prescribe it or that a pharmacy can dispense it.

13. Pregnancy and Breastfeeding

Pregnancy and breastfeeding can change whether a medication, supplement, route, or dose is appropriate. Some products can harm an embryo or fetus, pass into breast milk, affect fertility, or require a washout period before conception.

Report pregnancy, possible pregnancy, plans to conceive, fertility treatment, and breastfeeding before treatment and whenever status changes.
Do not assume that a topical, low-dose, "microdose," compounded, natural, or OTC product is safe in pregnancy.
Never use isotretinoin during pregnancy.
Avoid unintended exposure to finasteride or dutasteride products during pregnancy.
Ask before using retinoids, spironolactone, GLP-1 drugs, boric acid, methylene blue, hormone therapies, or sleep medications during pregnancy or breastfeeding.

14. When to Call 911 Instead of NoTimeRx

NoTimeRx is not an emergency service. Call 911 or go to the nearest emergency department for chest pain, severe trouble breathing, signs of stroke, loss of consciousness, severe allergic reaction, uncontrolled bleeding, seizure, severe confusion, suspected overdose, an erection lasting more than four hours, suicidal intent, or another urgent or life-threatening condition.

In the United States, call or text 988 for the Suicide & Crisis Lifeline. For a suspected poisoning or accidental ingestion, contact Poison Control at 1-800-222-1222. These resources do not replace emergency services when immediate danger is present.

15. Reporting Side Effects, Quality Problems, or Labeling Errors

Contact the prescribing provider and dispensing pharmacy for clinical questions, unexpected effects, dosing confusion, broken seals, temperature problems, missing directions, suspected contamination, or a label that appears inaccurate. Serious adverse events, medication errors, and product-quality problems may also be reported to FDA MedWatch.

NoTimeRx support

Biotica Consulting LLC d/b/a NoTimeRx
1404 Oak Tree Rd
Ste 4 #282
Iselin, NJ 08830
USA

Email: info@notimerx.com

16. Official Regulatory References

These references provide general U.S. regulatory and safety information. Product-specific labeling, provider instructions, and pharmacy instructions remain controlling for your treatment.

Product availability, formulations, pharmacy partners, laws, FDA shortage status, and program requirements can change. NoTimeRx may update this page as information changes. The date at the top shows when the page was last reviewed.

Safety Information